Methamphetamine Prevention and Awareness in the Pharmacy 2024
Methamphetamine Prevention and Awareness in the Pharmacy 2024
Pharmacists and pharmacy technicians have a critical role in the national efforts to reduce the illegal production of methamphetamine in the United States. The Combat Methamphetamine Epidemic Act of 2005 tasks pharmacy associates with abiding by rules that regulate the sale of over-the-counter pseudoephedrine and ephedrine products, drugs that are used in illegal methamphetamine manufacturing.
Upon successful completion of this knowledge-based course, learners should be able to:
1. Recognize the role of pseudoephedrine and ephedrine in methamphetamine production and explain current trends.
2. Identify the dangers methamphetamine abuse has on the individual and society.
3. Discuss valid patient identification process for the purchase of pseudoephedrine and ephedrine products.
4. Demonstrate understanding of pharmacy record-keeping for pseudoephedrine and ephedrine purchases.
5. Evaluate pseudoephedrine and ephedrine federal purchase limits.
Jenny Svendsen
Executive Director
National LGBTQ Cancer Network
Jenny Svendsen has no relevant financial relationships with ineligible companies to disclose.
Course fee includes course and course materials.
Course is non-refundable.
Release Date: January 1, 2024
Expiration Date: December 31, 2024
THIS COURSE DOES NOT PROVIDE CPE CREDIT
Additional information
| Duration | 0h 30m |
|---|---|
| Topic Designator | Compliance & Regulatory |
| ACPE | No |
| ACPE Topic | |
| Role | Pharmacist |
| Media-Type | Written |
| Release Date | 1/1/24 |
| CEUs | 0 |
| Rating | 4 |
